In this episode of the IMF’s #AskDrDurie web series, Dr. Brian G.M. Durie talks about when and for what kind of myeloma patient an autologous stem cell transplant (ASCT) is recommended.

Dr. Brian G.M. Durie serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is Chairman of the IMF's International Myeloma Working Group, a consortium of nearly 200 myeloma experts from around the world. Dr. Durie also leads the IMF’s Black Swan Research Initiative®.